We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
-19.94%
1 Year Est. Return
+35.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$74M
AUM Growth
-$32.8M
Cap. Flow
-$14M
Cap. Flow %
-18.88%
Top 10 Hldgs %
57.13%
Holding
106
New
12
Increased
9
Reduced
42
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 21.3%
2 Financials 18.15%
3 Consumer Discretionary 9.23%
4 Communication Services 8.92%
5 Technology 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARRY
51
DELISTED
Array Biopharma Inc
ARRY
$222K 0.3%
15,564
-3,149
-17% -$47.8K
GDX icon
52
VanEck Gold Miners ETF
GDX
$27.4B
$218K 0.29%
10,327
-2,356
-19% -$46.2K
GBT
53
DELISTED
Global Blood Therapeutics, Inc.
GBT
$208K 0.28%
5,071
-3,075
-38% -$115K
NBIS
54
Nebius Group N.V.
NBIS
$47.7B
$202K 0.27%
7,380
-1,033
-12% -$30.3K
XOP icon
55
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
$201K 0.27%
+1,897
New +$265K
FOLD
56
DELISTED
Amicus Therapeutics
FOLD
$173K 0.23%
18,053
+2,081
+13% +$22.9K
SPPI
57
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$154K 0.21%
17,554
-20,036
-53% -$255K
DO
58
DELISTED
Diamond Offshore Drilling
DO
$122K 0.16%
12,967
-16,513
-56% -$234K
IOVA icon
59
Iovance Biotherapeutics
IOVA
$2.87B
$121K 0.16%
+13,655
New +$132K
VKTX icon
60
Viking Therapeutics
VKTX
$4B
$90K 0.12%
11,703
-7,089
-38% -$84.8K
ZYNE
61
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$35K 0.05%
11,703
-7,089
-38% -$38.8K
EQS icon
62
Equus Total Return
EQS
$16.8M
$34K 0.05%
17,286
MTL.PR
63
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$25K 0.03%
38,123
-2,006
-5% -$1.51K
GMO
64
DELISTED
General Moly, Inc.
GMO
$4K 0.01%
17,982
-946
-5% -$215
APA icon
65
APA Corp
APA
$13.2B
-7,593
Closed -$362K
BTU icon
66
Peabody Energy
BTU
$2.9B
-6,594
Closed -$235K
CLF icon
67
Cleveland-Cliffs
CLF
$6.99B
-10,785
Closed -$137K
CLLS
68
Cellectis
CLLS
$285M
-18,792
Closed -$530K
CTRA
69
DELISTED
Coterra Energy
CTRA
-14,205
Closed -$320K
GDXJ icon
70
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
-8,903
Closed -$244K
GSK icon
71
GSK
GSK
$106B
-10,024
Closed -$503K
INTC icon
72
Intel
INTC
$513B
-5,160
Closed -$244K
MDGL icon
73
Madrigal Pharmaceuticals
MDGL
$11.8B
-1,253
Closed -$268K
NERV icon
74
Minerva Neurosciences
NERV
$199M
-1,253
Closed -$126K
NKTR icon
75
Nektar Therapeutics
NKTR
$2.58B
-573
Closed -$524K

Similar funds

Kazazian Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Kazazian Asset Management held 106 positions worth $74M, down 31% from $107M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Kazazian Asset Management withdrew a net $14M in Q4 2018, closing 42 positions and reducing 42 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $1.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kazazian Asset Management opened a new position in iShares Russell 2000 ETF worth $6.64M.

  • Kazazian Asset Management's largest Q4 2018 buy was iShares Russell 2000 ETF: 49,629 shares worth $6.64M.
  • Kazazian Asset Management added most to Apple in Q4 2018, an estimated $3.22M increase.
  • Kazazian Asset Management's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $8.03M.
  • Kazazian Asset Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2018, selling an estimated $1.6M.
  • Kazazian Asset Management's ten largest holdings make up 57% of its $74M portfolio in Q4 2018.
  • Kazazian Asset Management opened 12 new positions and closed 42 in Q4 2018.
  • Kazazian Asset Management's portfolio value fell 31% quarter-over-quarter to $74M.

Based on Kazazian Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.